Levetiracetam ER
NDC 71205-881, Levetiracetam, tablet, film coated, extended release, from Proficient Rx LP.
- Product NDC
- 71205-881
- Status
- Listed
- Labeler
- Proficient Rx LP
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205130
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71205-881 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM750 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71205-881-00 | 71205088100 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-00) |
| 71205-881-11 | 71205088111 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-11) |
| 71205-881-30 | 71205088130 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-30) |
| 71205-881-55 | 71205088155 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-55) |
| 71205-881-60 | 71205088160 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-60) |
| 71205-881-64 | 71205088164 | 240 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-64) |
| 71205-881-72 | 71205088172 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-72) |
| 71205-881-78 | 71205088178 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-78) |
| 71205-881-90 | 71205088190 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-881-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/57b9dccb-6ee6-4e89-ab26-4c478e2df2b5
Use it
Look up 71205-881 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71205-881 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71205-881. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.